ClinicalTrials.gov record
Recruiting Phase 2 Interventional

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

ClinicalTrials.gov ID: NCT07002034

Public ClinicalTrials.gov record NCT07002034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 4:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Adjustment Disorder in Patients With Cancer and Other Medical Illnesses

Study identification

NCT ID
NCT07002034
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Reunion Neuroscience Inc
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • RE104 for Injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 29, 2025
Primary completion
Oct 31, 2026
Completion
Nov 30, 2026
Last update posted
May 5, 2026

2025 – 2026

United States locations

U.S. sites
28
U.S. states
24
U.S. cities
28
Facility City State ZIP Site status
UAB, Psychiatry and Behavioral Neurology Birmingham Alabama 35209 Recruiting
University of Arizona Tucson Arizona 85724 Recruiting
Kadima Neuropsychiatry Institute San Diego California 92037 Recruiting
Providence Medical Foundation Santa Rosa California 95403 Recruiting
University of Colorado Aurora Colorado 80045 Recruiting
University of South Florida, Department of Psychiatry and Behavioral Neuroscience Tampa Florida 33613 Recruiting
Emory University Atlanta Georgia 30329 Recruiting
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 Recruiting
Rush University Medical Center Chicago Illinois 60612 Recruiting
The University of Kansas Medical Center Kansas City Kansas 66160 Recruiting
LSU Health Shreveport Shreveport Louisiana 71103 Recruiting
Sunstone Therapies, PC Rockville Maryland 20850 Recruiting
Sheppard Pratt Towson Maryland 21204 Recruiting
Dana Farber Cancer Institute Boston Massachusetts 02215 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
Henry Ford Health Novi Michigan 48377 Recruiting
University of Nebraska Medical Center Omaha Nebraska 68198 Recruiting
University of New Mexico, School of Medicine Albuquerque New Mexico 87131 Recruiting
NYU Langone Center for Psychedelic Medicine New York New York 10016 Recruiting
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 Recruiting
Cleveland Clinic Cleveland Ohio 44113 Recruiting
The Ohio State University, Department of Psychiatry Columbus Ohio 43210 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
Alliance for Multispecialty Research Clinical Knoxville Tennessee 37920 Recruiting
Dell Medical School, University of Texas at Austin Austin Texas 78712 Recruiting
Cedar Clinical Research Inc. Draper Utah 84020 Recruiting
UVA Center for Psychiatric Clinical Research Charlottesville Virginia 22903 Recruiting
Seattle Neuropsychiatric Treatment Center Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07002034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07002034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →